Diagnostics & Research
The Diagnostics & Research industry has a total of 48 stocks, with a combined market cap of $636.16 billion, total revenue of $169.13 billion and a weighted average PE ratio of 35.97.
Market Cap
636.16B
Revenue
169.13B
Profits
17.68B
PE Ratio
35.97
Profit Margin
10.46%
Dividend Yield
0.26%
48 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 167.89B | 0.89% | 2,851,702 | 45.20B |
| 2 | DHR | Danaher Corporation | 121.11B | 2.44% | 4,158,761 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 43.67B | 1.30% | 619,025 | 4.45B |
| 4 | WAT | Waters Corporation | 33.51B | 2.42% | 904,297 | 3.77B |
| 5 | A | Agilent Technologies, Inc. | 32.15B | 2.90% | 3,018,294 | 7.07B |
| 6 | NTRA | Natera, Inc. | 29.35B | 4.53% | 1,513,928 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 28.62B | -0.97% | 2,160,359 | 16.63B |
| 8 | MTD | Mettler-Toledo International Inc. | 21.88B | 3.04% | 214,247 | 4.09B |
| 9 | ILMN | Illumina, Inc. | 21.47B | 0.17% | 1,455,926 | 4.39B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.45B | 1.76% | 948,706 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 21.11B | 1.47% | 400,192 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 15.25B | 17.09% | 4,471,767 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.05B | 0.47% | 376,204 | 2.68B |
| 14 | RVTY | Revvity, Inc. | 10.58B | -1.12% | 1,423,382 | 2.90B |
| 15 | ICLR | ICON Public Limited Company | 8.79B | 1.36% | 859,077 | 8.10B |
| 16 | CRL | Charles River Laboratories International, Inc. | 7.52B | 2.36% | 880,564 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.26B | 2.48% | 1,647,636 | 2.10B |
| 18 | SHC | Sotera Health Company | 4.43B | 2.10% | 2,682,164 | 1.19B |
| 19 | RDNT | RadNet, Inc. | 4.26B | 1.61% | 400,421 | 2.14B |
| 20 | BLLN | BillionToOne, Inc. | 3.84B | 1.32% | 676,380 | 354.54M |
| 21 | VCYT | Veracyte, Inc. | 3.61B | 8.40% | 1,181,491 | 541.74M |
| 22 | TWST | Twist Bioscience Corporation | 3.34B | 8.40% | 2,111,768 | 409.48M |
| 23 | GRAL | GRAIL, Inc. | 2.83B | 8.26% | 748,894 | 156.12M |
| 24 | ADPT | Adaptive Biotechnologies Corporation | 2.23B | 7.72% | 1,918,910 | 295.41M |
| 25 | WGS | GeneDx Holdings Corp. | 1.33B | 6.17% | 1,143,982 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.16B | 6.08% | 1,316,047 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.09B | 3.02% | 1,320,583 | 412.82M |
| 28 | OPK | OPKO Health, Inc. | 928.76M | 6.96% | 2,881,277 | 581.12M |
| 29 | PSNL | Personalis, Inc. | 832.53M | 12.93% | 2,697,240 | 64.52M |
| 30 | CSTL | Castle Biosciences, Inc. | 607.51M | 4.32% | 425,112 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 466.05M | 2.88% | 609,920 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 359.85M | 7.32% | 2,099,048 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 260.34M | 5.81% | 211,709 | 92.39M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 199.86M | 11.33% | 442,001 | 1.95M |
| 35 | BNR | Burning Rock Biotech Limited | 176.12M | - | 2,207 | 77.14M |
| 36 | BDSX | Biodesix, Inc. | 145.26M | 3.08% | 13,642 | 96.10M |
| 37 | FONR | FONAR Corporation | 123.84M | 0.16% | 123,669 | 105.34M |
| 38 | XGN | Exagen Inc. | 92.53M | 2.68% | 202,281 | 68.38M |
| 39 | MDXH | MDxHealth SA | 45.20M | 4.85% | 402,528 | 110.97M |
| 40 | PRPO | Precipio, Inc. | 42.94M | -2.51% | 31,486 | 25.83M |
| 41 | QUCY | Quantum Cyber N.V. | 41.18M | 30.56% | 24,113,658 | 537.08K |
| 42 | MBAI | Check-Cap Ltd. | 13.34M | 1.10% | 86,094 | - |
| 43 | XWEL | XWELL, Inc. | 11.57M | - | 54,653 | 29.21M |
| 44 | NOTV | Inotiv, Inc. | 9.38M | 4.48% | 524,375 | 507.36M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 7.46M | -2.35% | 178,395 | 5.66M |
| 46 | ADVB | Advanced Biomed Inc. | 7.26M | 0.45% | 46,968 | - |
| 47 | NDRA | ENDRA Life Sciences Inc. | 6.89M | -0.72% | 20,730 | - |
| 48 | ISPC | iSpecimen Inc. | 6.13M | -7.36% | 168,403 | 1.03M |